Global Anti-Obesity Prescription Drugs Market Overview and Key Drivers 2032
Anti-Obesity Prescription Drugs Market to Reach USD 4.35 Billion by 2032, Driven by Rising Global Obesity Rates The Anti-Obesity Prescription Drugs Market was valued at USD 2.97 billion in 2024 and is projected to reach USD 4.35 billion by 2032, expanding at a CAGR of 4.9% during 2025–2032. The market is witnessing steady growth due to the alarming rise in...
0 Reacties 0 aandelen 9 Views 0 voorbeeld